Gedea Biotech strengthens its Board with extensive commercial expertise to support next phase
PRESS RELEASE Lund, Sweden – November 18, 2025 Gedea Biotech, an innovative Swedish life science company in women’s health, today announced the appointment of three new members to its Board of Directors: Paan Hermansson, Berit Lindholm, and Caroline Mofors. “- We are very fortunate to bring strong…
New insights into the vaginal microbiome: Emilia Lahtinen’s industrial PhD journey
At the intersection of academic research and biotech innovation, Emilia Lahtinen is pursuing her industrial PhD as a collaboration between Gedea Biotech and Karolinska Institutet (KI). Her research explores one of the
Gedea Biotech Announces CE-Marking for pHyph: A Novel Antibiotic-Free Treatment for Bacterial Vaginosis
Lund, Sweden – September 2, 2025 – Gedea Biotech, an innovative Swedish life science company, today announced that its lead product pHyph has received CE-marking under the EU Medical Device Regulation (MDR) for the treatment of bacterial vaginosis (BV). pHyph is an antibiotic-free vaginal tablet…
PRESS RELEASE Gedea Biotech Receives US Patent for Preventing Preterm Birth
Lund, Sweden, March 27, 2025 Gedea Biotech announced today that the United States Patent and Trademark Office (USPTO) has granted the company’s patent application covering the active ingredient in the company’s first product, pHyph, to prevent preterm birth (premature delivery) in pregnant women…
Gedea Biotech Reports Significant Results in Study for the Treatment of Bacterial Vaginosis
PRESS RELEASE Lund, Sweden, March 12, 2025 Gedea Biotech has completed a clinical study, the NEFERTITI-2 study, for the treatment of bacterial vaginosis, showing significantly better treatment outcomes with the company's vaginal tablet pHyph compared to the control group. This result forms the…
Gedea wins prestigious scale up award
On Thursday November 28th, at the Nordic Mentor Network For Entrepreneurship - NOME annual meeting in Copenhagen, we were honored to receive the Arvind Hundal Scale-up Award for “showing inspirational growth.” We are proud, humbled, and truly grateful for this recognition. Following in the…
Emilia, industrial doctoral student at Gedea and Karolinska Institutet
Emilia Lahtinen is n industrial Ph.D. student at Gedea and at Karolinska Institutet. Her project has the title Bacterial vaginosis: Understanding the impact of antibiotic and antibiotic-free treatments on the vaginal microbiome and risk of recurrence. Please meet her in this short interview.……
Anna-Karin Areskog strengthens the team
Gedea has recently strengthened its team by hiring Anna-Karin Areskog as QA Director. Anna-Karin has been a consultant with the company since April 2023 and is now a permanent employee. In her new role, she will focus on the CE marking of pHyph and initiate the commercial-scale production of…
Gedea´s share issue oversubscribed by 54%
Gedea Biotech AB carried out a rights issue of SEK 24.3 million during October. The interest from both existing owners and new investors exceeded the board’s mandate, and an extraordinary general meeting resolved a directed issue to include the oversubscription of SEK 13 million. In total, Gedea…